Interim PET-directed therapy in limited stage Hodgkin lymphoma initially treated with ABVD.

Diego Villa,Laurie H Sehn,Christina Aquino-Parsons,Petter Tonseth,David W Scott,Alina S Gerrie,Donald Wilson,François Bénard,Randy D Gascoyne,Graham W Slack,Pedro Farinha,James Morris,Tom Pickles,Joseph M Connors,Kerry J Savage

HAEMATOLOGICA（2018）

引用 13|浏览23

暂无评分

摘要

Limited-stage Hodgkin lymphoma (HL) is a highly curable malignancy when treated with combination chemotherapy with or without radiotherapy (RT).[1][1]–[5][2] The majority of patients experience long-term survival but remain at risk for late treatment-related complications, particularly those

查看译文

关键词

Hodgkin's Lymphoma,PET,early Hodgkin lymphoma,interim PET,limited stage Hodgkin lymphoma

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要